REQUEST A DEMO
Total
USD $0.00
Search more companies

Ives Drugs ( India) Pvt.Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ives Drugs ( India) Pvt.Ltd. Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ives Drugs ( India) Pvt.ltd. is an unlisted company, incorporated on 17/04/1986. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24232MP1986PTC003375 and registration number is 003375.

Headquarters
504 Chetak Centre 12/2 R.N.T. Marg Indore In-Mp In 452001
Indore; Madhya Pradesh; Postal Code: 452001

Contact Details: Purchase the Ives Drugs ( India) Pvt.Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Ives Drugs ( India) Pvt.Ltd. report to view the information.
Outstanding Shares:
Purchase the Ives Drugs ( India) Pvt.Ltd. report to view the information.
Registered Capital:
Purchase the Ives Drugs ( India) Pvt.Ltd. report to view the information.
Incorporation Date:
April 17, 1986
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Ives Drugs ( India) Pvt.Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.71%
Total operating revenue
0.71%
Operating profit (EBIT)
949.41%
EBITDA
14.39%
Net Profit (Loss) for the Period
-23.54%
Total assets
4.92%
Total equity
708.74%
Operating Profit Margin (ROS)
0.37%
Net Profit Margin
-0.66%
Return on Equity (ROE)
-151.56%
Debt to Equity Ratio
-2181.91%
Quick Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?